Complementary, alternative medicine integration into clinical cancer care needs to be individualized
the ONA take:
Researchers at the Abramson Cancer Center at the University of Pennsylvania’s Perelman School of Medicine conducted a survey-based study to determine what drives the use of complementary and alternative medicine (CAM) among cancer patients.
The researchers surveyed 969 patients from the institution’s thoracic, breast, and gastrointestinal medical oncology clinics.
The findings reveal that expectation of therapeutic benefits, patient-perceived barriers regarding cost and access, and opinions of patients’ physician and family members predict patients’ use of CAM.
These beliefs and attitudes varied by key socio-demographic factors such as sex, race, and education.
Proven effectiveness of CAM practices such as yoga and acupuncture continue to support the practice of integrative oncology, which merges complementary and alternative medicine with conventional medicine to improve patient outsomes.
The researchers conclude that patient education on CAM practices should be tailored to the individual patient when integrating them into clinical care.
A study to determine what drives the use of complementary and alternative medicine among cancer patients.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|